Zimmer Biomet Holdings (NYSE: ZBH) reported Q1 EPS of $1.94, $0.07 better than the analyst estimate of $1.87. Revenue for the quarter came in at $1.89 billion versus the consensus estimate of $1.87 billion.

GUIDANCE:

Zimmer Biomet Holdings sees FY 2024 EPS of $8.00-$8.15, versus the consensus of $8.05.

For earnings history and earnings-related data on Zimmer Biomet Holdings (ZBH) click here.